- Home
- CVS vs JSPRW Comparison
CVS vs JSPRW Comparison
Compare CVS & JSPRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVS
- JSPRW
- Stock Information
- Founded
- CVS 1963
- JSPRW N/A
- Country
- CVS United States
- JSPRW United States
- Employees
- CVS N/A
- JSPRW 45
- Industry
- CVS Retail-Drug Stores and Proprietary Stores
- JSPRW Biotechnology: Pharmaceutical Preparations
- Sector
- CVS Consumer Staples
- JSPRW Health Care
- Exchange
- CVS Nasdaq
- JSPRW Nasdaq
- Market Cap
- CVS N/A
- JSPRW N/A
- IPO Year
- CVS N/A
- JSPRW 2020
- Fundamental
- Price
- CVS $52.99
- JSPRW $0.15
- Analyst Decision
- CVS Buy
- JSPRW
- Analyst Count
- CVS 16
- JSPRW 0
- Target Price
- CVS $69.25
- JSPRW N/A
- AVG Volume (30 Days)
- CVS 13.2M
- JSPRW N/A
- Earning Date
- CVS 02-12-2025
- JSPRW N/A
- Dividend Yield
- CVS 5.02%
- JSPRW N/A
- EPS Growth
- CVS N/A
- JSPRW N/A
- EPS
- CVS 3.95
- JSPRW N/A
- Revenue
- CVS $367,246,000,000.00
- JSPRW N/A
- Revenue This Year
- CVS $5.33
- JSPRW N/A
- Revenue Next Year
- CVS $4.18
- JSPRW N/A
- P/E Ratio
- CVS $13.40
- JSPRW N/A
- Revenue Growth
- CVS 5.96
- JSPRW N/A
- 52 Week Low
- CVS $43.56
- JSPRW N/A
- 52 Week High
- CVS $80.75
- JSPRW N/A
- Technical
- Relative Strength Index (RSI)
- CVS 63.49
- JSPRW N/A
- Support Level
- CVS $50.63
- JSPRW N/A
- Resistance Level
- CVS $52.28
- JSPRW N/A
- Average True Range (ATR)
- CVS 1.45
- JSPRW 0.00
- MACD
- CVS 1.17
- JSPRW 0.00
- Stochastic Oscillator
- CVS 94.79
- JSPRW 0.00
About JSPRW Japer Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.